Evidence map›Paper›PMID 38368386›Full record

ArticleBMC plant biology2024

Trichoderma cf. asperellum and plant-based titanium dioxide nanoparticles initiate morphological and biochemical modifications in Hordeum vulgare L. against Bipolaris sorokiniana.

Rabab A Metwally, Shereen A Soliman, Hanan Abdalla, Reda E Abdelhameed

Open access · goldAbstract read
In one paragraph

Article in BMC plant biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. TiOPlant signaling & behavior · 2025
    Article
  8. Article
  9. Synergistic Effect of TiOAntioxidants (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review of Antimicrobial Properties of Titanium Dioxide Nanoparticles.International journal of molecular sciences · 2024
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rabab A MetwallyBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. rababmicro2009@gmail.com.
Shereen A SolimanBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Hanan AbdallaBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Reda E AbdelhameedBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpot blotch is a serious foliar disease of barley (Hordeum vulgare L.) plants caused by Bipolaris sorokiniana, which is a hemibiotrophic ascomycete that has a global impact on productivity. Some Trichoderma spp. is a promising candidate as a biocontrol agent as well as a plant growth stimulant. Also, the application of nanomaterials in agriculture limits the use of harmful agrochemicals and helps improve the yield of different crops. The current study was carried out to evaluate the effectiveness of Trichoderma. cf. asperellum and the biosynthesized titanium dioxide nanoparticles (TiO

resultsAloe vera L. aqueous leaf extract was used to biosynthesize TiO

conclusionSubsequently, T. cf. asperellum and TiO

Indexed as

BipolarisHordeumHypocrealesNanoparticlesTitaniumTrichodermaPlant DiseasesTitaniumtitanium dioxideAntagonistic activityAntioxidative enzymesBarleyBiocontrol agentCell free filtrateGreen synthesisSpot blotch diseaseTrichoderma cf. asperellum

Identifiers

PMID38368386
PMCPMC10873961
OpenAlexW4391913539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.